Clinical Practice

Use the tool below to view all available Global Kidney Academy Series

The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
MinuteCE®
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
1.00 program credit
Navigating KDIGO Guidance in IgAN
Navigating KDIGO Guidance in IgAN
MinuteCE®
Navigating KDIGO Guidance in IgAN
Jonathan Barratt, MD, PhD; Jörg Latus, MD
1.00 program credit
- Jonathan Barratt, MD, PhD
- Jörg Latus, MD
1.00 program credit
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
MinuteCE®
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Jörg Latus, MD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- Jörg Latus, MD
1.00 program credit
Translating Evidence into IgAN Care
Translating Evidence into IgAN Care
MinuteCE®
Translating Evidence into IgAN Care
Jonathan Barratt, MD, PhD; Jörg Latus, MD
1.00 program credit
- Jonathan Barratt, MD, PhD
- Jörg Latus, MD
1.00 program credit
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
MinuteCE®
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD; Federico Alberici, MD, PhD
1.00 credit 9 episodes
- Steven Fishbane, MD
- Federico Alberici, MD, PhD
- Nancy Helou, PhD
- Anastasia Liossatou, PhD, RN
1.00 credit 9 episodes
Gabapentinoids: Safety Considerations and Downstream Outcomes
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®
Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Spotlight on Assessment: Tools That Capture CKD-aP
Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Winning the CKD-aP Battle: A United Physician-Nurse Front
Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®
Winning the CKD-aP Battle: A United Physician-Nurse Front
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Reading Between the Lines: What PROMs Reveal About Itch
Reading Between the Lines: What PROMs Reveal About Itch
MinuteCE®
Reading Between the Lines: What PROMs Reveal About Itch
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CE
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
Elevating CKD-aP Care: New Frontier 
Elevating CKD-aP Care: New Frontier 
MinuteCE®
Elevating CKD-aP Care: New Frontier 
James Burton, DM, FRCP; Lucio Manenti, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Lucio Manenti, MD, PhD
1.00 program credit
Is CKD-aP Hiding in Your Dialysis Center?
Is CKD-aP Hiding in Your Dialysis Center?
MinuteCE®
Is CKD-aP Hiding in Your Dialysis Center?
James Burton, DM, FRCP; Emilio Sanchez, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit

Clinical Practice

Popular

Title

Welcome to Global Kidney Academy

Welcome to Global
Kidney Academy